<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04781868</url>
  </required_header>
  <id_info>
    <org_study_id>13032</org_study_id>
    <nct_id>NCT04781868</nct_id>
  </id_info>
  <brief_title>Multi-Nutrient Supplement for Radio-Protection</brief_title>
  <acronym>MNSRP</acronym>
  <official_title>Multi-Nutrient Supplement for Radio-Protection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exposure to radiation, such as during routine CTs, bone scans, or X-rays, causes oxidative&#xD;
      stress which can damage the DNA (your genetic material) within your white blood cells. While&#xD;
      the amount of DNA damage that may occur from one scan is not harmful to your overall health,&#xD;
      there could be concerning damage in patients who are constantly exposed to this radiation.&#xD;
      Currently, there is no way to prevent DNA damage during a medical scan. One potential way to&#xD;
      fight the oxidative stress caused by radiation is to take an antioxidant before a scan. The&#xD;
      purpose of this study is to see if a combination of antioxidants can protect someone from the&#xD;
      damage that radiation causes to the DNA of their white blood cells.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of gamma-H2Ax foci per PBMC nucleus</measure>
    <time_frame>Three hours following radiation exposure</time_frame>
    <description>Number of gamma-H2Ax foci per PBMC nucleus three hours following radiation exposure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of amplifiable mtDNA in PBMC's</measure>
    <time_frame>Three hours following radiation exposure</time_frame>
    <description>Amount of amplifiable mtDNA in PBMC's three hours following radiation exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abundance of mtDNA deletions in PBMC's</measure>
    <time_frame>Three hours following radiation exposure</time_frame>
    <description>Abundance of mtDNA deletions in PBMC's three hours following radiation exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abundance of phosphorus-ATM in PBMC's</measure>
    <time_frame>Three hours following radiation exposure</time_frame>
    <description>Abundance of phosphorus-ATM in PMBC's three hours following radiation exposure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Oxidative Stress</condition>
  <condition>DNA Damage, Radiation Induced</condition>
  <condition>Radiation Exposure</condition>
  <arm_group>
    <arm_group_label>Multi-nutrient supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Multi-nutrient supplement</intervention_name>
    <description>Multi-nutrient supplement containing a combination of vitamins, minerals and antioxidants</description>
    <arm_group_label>Multi-nutrient supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 to 76 years.&#xD;
&#xD;
          -  Scheduled for bone scan procedure at the Juravinski Hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of smoking within six months prior to study enrollment.&#xD;
&#xD;
          -  Known hypersensitivity reactions to any of the ingredients in the MNSRP.&#xD;
&#xD;
          -  Chemotherapy or radiation therapy within six months prior or one month following study&#xD;
             enrollment.&#xD;
&#xD;
          -  Individuals currently taking vitamin or mineral supplements that contain antioxidants&#xD;
             will be considered on a case-by-case basis but will be asked to refrain from intake&#xD;
             for at least two weeks prior to partaking in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2021</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

